Microfluidic Nanobiosensor Detection of Botulinum Neurotoxin Serotype A

Area of Science:

• Biotechnology
• Nanotechnology
• Analytical Chemistry

Background:

• Botulinum neurotoxin (BoNT) is a potent toxin causing life-threatening botulism, often via contaminated food.
• Current detection methods like the mouse bioassay are slow and ethically problematic.
• Rapid, field-deployable, and animal-free BoNT detection methods are urgently needed.

Purpose of the Study:

• To develop a microfluidic nanobiosensor for rapid, sensitive, and user-friendly detection of active BoNT.
• To utilize droplet-based passive pumping and quantum dots (QDs) for efficient sample handling and signal generation.
• To provide an alternative to animal-based assays for BoNT detection in various settings.

Main Methods:

• Development of a microfluidic device employing droplet-based passive pumping for sample introduction.
• Immobilization of QDs onto microfluidic channels via BoNT serotype-specific peptides.
• Detection based on the reduction of QD photoluminescence due to BoNT-induced peptide cleavage.

Main Results:

• Successful detection of the light chain of BoNT serotype A (LcA) within a concentration range of 1 ng/mL to 100 μg/mL.
• Achieved a limit of detection (LoD) of 1 ng/mL (20 pM) for LcA.
• Demonstrated detection in a small sample volume (1 pg LcA in 1 μL) within 2 hours.

Conclusions:

• The developed microfluidic nanobiosensor offers a rapid, low-cost, and user-friendly method for detecting active BoNT.
• The biosensor effectively detects BoNT's endopeptidase activity without using laboratory animals.
• This technology presents a scalable solution for potential field or low-resource BoNT screening.